Effect of renal function on skeletal health in primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 5, 2012, Pages 1501-1507

  Walker, Marcella D ^a   Dempster, David W ^b,c   McMahon, Donald J ^a   Udesky, Julia ^a   Shane, Elizabeth ^a   Bilezikian, John P ^a   Silverberg, Shonni J ^a  

^a Department of Medicine ^*  (United States)

^b Department of Pathology ^*  (United States)

^c HELEN HAYES HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE EROSION; BONE METABOLISM; BONE REMODELING; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLOMERULUS FILTRATION RATE; HORMONE URINE LEVEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MORPHOMETRICS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY;

ADULT; AGED; BONE AND BONES; BONE DENSITY; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84860749874     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3072     Document Type: Article

References (23)

1. Bilezikian JP, Khan AA, Potts Jr JT 2009 Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94:335-339
2. Fajtova VT, Sayegh MH, Hicke YN, Aliabad IP, Lazarus JM, Le Boff MS 1995 Intact parathyroid hormone levels in renal insufficiency. Calcif Tissue Int 57:329-335
3. Tassone F, Gianotti L, Emmolo I, Ghio M, Borretta G 2009 Glomerular filtration rate and parathyroid hormone secretion in primary hyperparathyroidism. J Clin Endocrinol Metab 94:4458-4461
4. Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G 2006 A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism. J Clin Endocrinol Metab 91:3011-3016
5. Hamdy NA, Kanis JA, Beneton MN, Brown CB, Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT 1995 Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358-363
6. Bacchetta J, Boutroy S, Vilayphiou N, Juillard L, Guebre-Egziabher F, Rognant N, Sornay-Rendu E, Szulc P, Laville M, Delmas PD, Fouque D, Chapurlat R 2010 Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res 25:849-857
7. Nickolas TL, McMahon DJ, Shane E 2006 Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17:3223-3232
8. Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL, Cauley JA, Jamal SA, Antoniucci DM, Cummings SR 2007 Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 167:133-139
9. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ 2008 The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93:3462-3470
10. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP 1999 A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249-1255
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: anew prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470
12. Kivirikko KI, Laitinen O, Prockop DJ 1967 Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 19:249-255
13. Dempster DW, Parisien M, Silverberg SJ, Liang XG, Schnitzer M, Shen V, Shane E, Kimmel DB, Recker R, Lindsay R, Bilezikian JP 1999 On the mechanism of cancellous bone preservation in postmenopausal women with mild primary hyperparathyroidism. J Clin Endocrinol Metab 84:1562-1566
14. Parisien M, Cosman F, Mellish RW, Schnitzer M, Nieves J, Silverberg SJ, Shane E, Kimmel D, Recker RR, Bilezikian JP, et al. 1995 Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res 10:1393-1399
15. Parisien M, Mellish RW, Silverberg SJ, Shane E, Lindsay R, Bilezikian JP, Dempster DW 1992 Maintenance of cancellous bone connectivity in primary hyperparathyroidism: trabecular strut analysis. J Bone Miner Res 7:913-919
16. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610
17. Peacock M 2002 Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17(Suppl 2):N87-N94
18. Dalle Carbonare L, Bertoldo F, Valenti MT, Zenari S, Zanatta M, Sella S, Giannini S, Cascio VL 2005 Histomorphometric analysis of glucocorticoid-induced osteoporosis. Micron 36:645-652
19. Cejka D, Herberth J, Branscum AJ, Fardo DW, Monier-Faugere MC, Diarra D, Haas M, Malluche HH 2011 Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6:877-882
20. Yamashita H, Noguchi S, Uchino S, Watanabe S, Murakami T, Ogawa T, Masatsugu T, Takamatsu Y, Miyatake E, Yamashita H 2003 Influence of renal function on clinico-pathological features of primary hyperparathyroidism. Eur J Endocrinol 148:597-602
21. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N 2005 Circulating FGF-23 is regulated by 1α, 25-dihydroxyvitamin D3 and phosphorus invivo. J Biol Chem 280:2543-2549
22. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435
23. Meunier PJ, Bressot C 1982 Endocrine influences on bone cells and bone remodeling evaluated by clinical histomorphometry. In: Parsons JA, ed. Endocrinology of calcium metabolism. New York: Raven Press